Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
Benjamin Hibbert, MD, PhD, addresses the need for randomized clinical trials to fill evidence gaps in cardiovascular care. Dr. Hibbert's group completed the DoReMi Study, an RCT comparing the use of dobutamine versus milrinone in cardiogenic shock, and has similarly themed studies underway.
[5:58] Cardiogenic shock
[8:59] Resident and fellow led research
[11:19] DOREMI trial
[23:26] Future directions
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
https://www.nejm.org/doi/full/10.1056/NEJMoa2026845
Follow the Yale Heart Failure program on Twitter.
https://twitter.com/YaleHF
Видео Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock канала Yale Cardiovascular Medicine Grand Rounds
[5:58] Cardiogenic shock
[8:59] Resident and fellow led research
[11:19] DOREMI trial
[23:26] Future directions
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock
https://www.nejm.org/doi/full/10.1056/NEJMoa2026845
Follow the Yale Heart Failure program on Twitter.
https://twitter.com/YaleHF
Видео Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock канала Yale Cardiovascular Medicine Grand Rounds
Показать
Комментарии отсутствуют
Информация о видео
5 ноября 2021 г. 2:47:19
00:41:01
Другие видео канала
![Rehospitalization of Patients with AHF Receiving Continuous Palliative Dobutamine or Milrinone](https://i.ytimg.com/vi/BtKBIlAKZXg/default.jpg)
![Using Mouse Models to Understand Disease Mechanism: Lessons From Cavernous Malformation and COVID-19](https://i.ytimg.com/vi/L0-TuI6nenE/default.jpg)
![Value and Innovation in Heart Failure: Perspectives from the Health System to the Individual Patient](https://i.ytimg.com/vi/J6U_mHIZgjw/default.jpg)
![Depression, Self-Care, and Rehospitalization in Heart Failure](https://i.ytimg.com/vi/AKOamrM4oU4/default.jpg)
![ITEACH](https://i.ytimg.com/vi/OYA3_XOdAmA/default.jpg)
![YNHHS Transition to High Sensitivity Troponin](https://i.ytimg.com/vi/rw6A22jvaqg/default.jpg)
![Preventive Cardiovascular Medicine through a 20/20 Lens](https://i.ytimg.com/vi/HD0YkWvSw4w/default.jpg)
![Swallowing & Laryngeal Complications following Heart Transplant](https://i.ytimg.com/vi/cBRm6nWf1mY/default.jpg)
![The Genetic Approach to Cardiovascular Diseases, Progress and Challenges](https://i.ytimg.com/vi/FjDY-0HHv8o/default.jpg)
![Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation](https://i.ytimg.com/vi/KkdOgNmW1kQ/default.jpg)
![Immunosuppression and reproductive health](https://i.ytimg.com/vi/X5ibx5CSB2Q/default.jpg)
![IABP Use in Cardiogenic Shock](https://i.ytimg.com/vi/r-WlkXA9Hcw/default.jpg)
![Approach to Antibody Sensitization in Heart Transplantation](https://i.ytimg.com/vi/9Rm39bLKrvQ/default.jpg)
![The Global Burden of Cardiovascular Diseases and Risks](https://i.ytimg.com/vi/CGhTR1y0B1o/default.jpg)
![AHA 2021 Late-Breaking Science](https://i.ytimg.com/vi/1X5YA5_nwCM/default.jpg)
![Hospital to home: strategies to improve outcomes following hospitalization for Heart Failure](https://i.ytimg.com/vi/KPKDhRRv6EY/default.jpg)
![Translational Genomics in Cardiovascular Disease](https://i.ytimg.com/vi/Y4ac2WB6YEI/default.jpg)
![Assessing and Managing Women with Angina: How Are We Doing? Women FiRST Trial: Directions at 1 Year](https://i.ytimg.com/vi/35dVAEV1wUs/default.jpg)
![From Marketing to Medicine: Uplift Modeling to Predict Individual Treatment Effects](https://i.ytimg.com/vi/FH9hJlsZtSg/default.jpg)
![CVM Grand Rounds: Academic Year 2023-2024](https://i.ytimg.com/vi/I6Mhhftc5dY/default.jpg)
![AV Junction Ablation and CRT for Patients with Permanent Afib and Narrow QRS](https://i.ytimg.com/vi/lhsDPRBuzT4/default.jpg)